Lialda Approved for Maintenance of Remission of Ulcerative Colitis - ONA
Links shared publicly online about this topic.
- 138total visits
Lialda Approved for Maintenance of Remission of Ulcerative Colitis - ONA
View full resource at oncologynurseadvisor.com
Tags: IBD, Ulcerative Colitis, Ulcerative Colitis Medication, Lialda, Asacol, Shire, Ulcer, Colitis
Most Recently Shared on July 18, 2011 at 3:05 pm By:
Lialda Approved for Maintenance of Remission of Ulcerative Colitis http://goo.gl/fb/slExm
Lialda® (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis
medicalnewstoday.com — “Shire plc (LSE: SHP; NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Release Ta” View full resource at medicalnewstoday.com
Most Recently Shared on July 20, 2011 at 9:07 am By:
MNT Drug Approvals Health News
Lialda® (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis http://mnt.to/3YpB #regulatory
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
drugs.com — “Lialda (mesalamine) is used to treat ulcerative colitis. Information from Drugs.com includes Lialda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 19, 2011 at 1:07 am By:
Drugs and Devices OW OW Health
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis: Lialda has be... http://bit.ly/pKdIFe #drug
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis
drugs.com — “Lialda (mesalamine) is used to treat ulcerative colitis. Information from Drugs.com includes Lialda side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on July 19, 2011 at 12:41 am By:
Lialda (Mesalamine) Now Approved in U.S. for Maintenance of Remission of Ulcerative Colitis - http://bit.ly/rbWZJQ
Lialda(R) (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Lialda® (mesalamine) Delayed Rele” View full resource at medicalnewstoday.com
Most Recently Shared on July 18, 2011 at 4:05 pm By:
MNT Drug Approvals Health News
Lialda(R) (Mesalamine) Now Approved In U.S. For Maintenance Of Remission Of Ulcerative Colitis http://mnt.to/3YkK #regulatory
Lialda Approved for Maintenance of Remission of Ulcerative Colitis - MPR
empr.com — “Shire announced that Lialda (mesalamine delayed-release tablets) has been approved for the maintenance of remission in patients with ulcerative colitis.” View full resource at empr.com
Most Recently Shared on July 18, 2011 at 3:07 pm By:
MPR News: Lialda Approved for Maintenance of Remission of Ulcerative Colitis: Shire announced that Lialda (mesal... http://bit.ly/qvyP3j
Advertisement
